# Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement

> **NCT03109925** · PHASE2 · UNKNOWN · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 23 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** DC Lumi Bead, BTG

## Key facts

- **NCT ID:** NCT03109925
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-02
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-06-29
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03109925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03109925, "Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03109925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*